DK3649124T3 - Fluorpiperidinforbindelser som rene 5-ht6-receptorantagonister - Google Patents

Fluorpiperidinforbindelser som rene 5-ht6-receptorantagonister Download PDF

Info

Publication number
DK3649124T3
DK3649124T3 DK18773832.3T DK18773832T DK3649124T3 DK 3649124 T3 DK3649124 T3 DK 3649124T3 DK 18773832 T DK18773832 T DK 18773832T DK 3649124 T3 DK3649124 T3 DK 3649124T3
Authority
DK
Denmark
Prior art keywords
fluorpiperide
pure
compounds
receptor antagonists
antagonists
Prior art date
Application number
DK18773832.3T
Other languages
English (en)
Inventor
Ramakrishna Nirogi
Anil Karbhari Shinde
Abdul Rasheed Mohammed
Rajesh Kumar Badange
Kumar Bojja
Vinod Kumar Goyal
Santosh Kumar Pandey
Jagadeesh Babu Thentu
Venkateswarlu Jasti
Original Assignee
Suven Life Sciences Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Suven Life Sciences Ltd filed Critical Suven Life Sciences Ltd
Application granted granted Critical
Publication of DK3649124T3 publication Critical patent/DK3649124T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/155—Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/235—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
    • A61K31/24—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group having an amino or nitro group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/473—Quinolines; Isoquinolines ortho- or peri-condensed with carbocyclic ring systems, e.g. acridines, phenanthridines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5375—1,4-Oxazines, e.g. morpholine
    • A61K31/538—1,4-Oxazines, e.g. morpholine ortho- or peri-condensed with carbocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Emergency Medicine (AREA)
  • Psychology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
DK18773832.3T 2017-08-07 2018-08-06 Fluorpiperidinforbindelser som rene 5-ht6-receptorantagonister DK3649124T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN201741028024 2017-08-07
PCT/IB2018/055894 WO2019030641A1 (en) 2017-08-07 2018-08-06 FLUOROPIPERIDINE COMPOUNDS AS PURE 5-HT 6 RECEPTOR ANAGONISTS

Publications (1)

Publication Number Publication Date
DK3649124T3 true DK3649124T3 (da) 2021-05-31

Family

ID=63678636

Family Applications (1)

Application Number Title Priority Date Filing Date
DK18773832.3T DK3649124T3 (da) 2017-08-07 2018-08-06 Fluorpiperidinforbindelser som rene 5-ht6-receptorantagonister

Country Status (26)

Country Link
US (1) US10973831B2 (da)
EP (1) EP3649124B1 (da)
JP (1) JP6808088B2 (da)
KR (1) KR102190332B1 (da)
CN (1) CN111051302B (da)
AU (1) AU2018313049B2 (da)
BR (1) BR112020002227A2 (da)
CA (1) CA3071084C (da)
CY (1) CY1124174T1 (da)
DK (1) DK3649124T3 (da)
EA (1) EA202090397A1 (da)
ES (1) ES2874628T3 (da)
HR (1) HRP20210822T1 (da)
HU (1) HUE055186T2 (da)
IL (1) IL272287B (da)
LT (1) LT3649124T (da)
MA (1) MA50036B1 (da)
MD (1) MD3649124T2 (da)
MX (1) MX2020001311A (da)
PL (1) PL3649124T3 (da)
PT (1) PT3649124T (da)
RS (1) RS61886B1 (da)
SG (1) SG11202000833YA (da)
SI (1) SI3649124T1 (da)
WO (1) WO2019030641A1 (da)
ZA (1) ZA202000758B (da)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2020286003A1 (en) * 2019-05-24 2021-12-02 Integrative Research Laboratories Sweden Ab Pharmaceutically acceptable salts of [2-(3-fluoro-5-methane-sulfonylphenoxy)ethyl](propyl)amine and uses thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2003293653B2 (en) * 2002-11-08 2009-05-14 F. Hoffmann-La Roche Ag Substituted benzoxazinones and uses thereof
US7378415B2 (en) * 2004-09-30 2008-05-27 Roche Palo Alto Llc Benzoxazine and quinoxaline derivatives and uses thereof
US7713954B2 (en) * 2004-09-30 2010-05-11 Roche Palo Alto Llc Compositions and methods for treating cognitive disorders

Also Published As

Publication number Publication date
MA50036B1 (fr) 2021-06-30
CY1124174T1 (el) 2022-05-27
SG11202000833YA (en) 2020-02-27
MD3649124T2 (ro) 2021-07-31
SI3649124T1 (sl) 2021-09-30
MX2020001311A (es) 2020-03-20
HRP20210822T1 (hr) 2021-08-20
US10973831B2 (en) 2021-04-13
CA3071084C (en) 2021-01-19
KR102190332B1 (ko) 2020-12-11
CN111051302B (zh) 2021-04-09
KR20200022517A (ko) 2020-03-03
EP3649124B1 (en) 2021-03-03
JP6808088B2 (ja) 2021-01-06
HUE055186T2 (hu) 2021-11-29
BR112020002227A2 (pt) 2020-07-28
IL272287A (en) 2020-03-31
ZA202000758B (en) 2021-03-31
RS61886B1 (sr) 2021-06-30
LT3649124T (lt) 2021-06-10
JP2020526573A (ja) 2020-08-31
CA3071084A1 (en) 2019-02-14
EP3649124A1 (en) 2020-05-13
US20200155560A1 (en) 2020-05-21
AU2018313049A8 (en) 2020-02-27
MA50036A (fr) 2020-05-13
CN111051302A (zh) 2020-04-21
IL272287B (en) 2021-07-29
AU2018313049A1 (en) 2020-02-20
EA202090397A1 (ru) 2020-05-25
WO2019030641A1 (en) 2019-02-14
PL3649124T3 (pl) 2021-08-16
ES2874628T3 (es) 2021-11-05
PT3649124T (pt) 2021-06-01
AU2018313049B2 (en) 2020-07-09
NZ762057A (en) 2022-03-25

Similar Documents

Publication Publication Date Title
DK3642224T3 (da) T-cellereceptorer
DK3697785T3 (da) Imidazo-pyridine forbindelser som pad-inhibitorer
DK3125893T3 (da) Deutererede heterocyklus-fusionerede gamma-carboliner som antagonister af 5-ht2a-receptorer
DK3728252T3 (da) 4-azaindolforbindelser
DK3442980T3 (da) Heterocykliske forbindelser som ret-kinase-hæmmere
DK3440102T3 (da) T-cellereceptorer
DK3406609T3 (da) Bicykliske aza-forbindelser som muskariniske receptoragonister
DK3533796T3 (da) Aminopyrazolopyrimidinforbindelse anvendt som neutrof faktor tyrosinkinasereceptor inhibitor
DK3768674T3 (da) Aminopyrimidinderivater som ctps1-hæmmere
DK3371190T3 (da) Heterocykliske forbindelser som pi3k-gamma-inhibitorer
DK3357919T3 (da) Aromatiske heterocykliske forbindelser som antiinflammatoriske forbindelser
DK3609898T3 (da) Forbindelser, der er nyttige som ret-hæmmere
DK3094631T3 (da) Pyrimidinyloxybenzenderivater som herbicider
DK3325487T3 (da) Formulering til bløde, anticholinerge analoger
DK3672951T3 (da) Quinoxalinderivater som adenosinreceptorantagonister
DK3544981T3 (da) Benzodiazoliumforbindelser som enac-inhibitorer
DK3265459T3 (da) Amidforbindelser som 5-ht4-receptoragonister
DK3303323T3 (da) Heterocykliske forbindelser af 3,3-difluorpiperidincarbamat som NR2B-NMDA-receptorantagonister
DK3130592T3 (da) ANALOGER AF 4H-PYRAZOLO[1,5-á]BENZIMIDAZOL-FORBINDELSER SOM PARPINHIBITORER
DK3661941T3 (da) Thiazolopyridinderivater som adenosinreceptor-antagonister
DK3145916T3 (da) Imidazolderivater som formylpeptidreceptormodulatorer
DK4056557T3 (da) Benzazepinderivater nyttige som medikamenter
DK3914600T3 (da) Thiazolopyridinderivater som adenosinreceptorantagonister
DK3180326T3 (da) Benzodiazepinderivater som cck2/gastrin-receptorantagonister
DK3558960T3 (da) Aromatiske carboxylsyreamider som antagonister for bradykinin-b1-receptor